U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749807) titled 'Nebulized Glubran 2-Assisted Tubeless PCNL Versus Conventional PCNL' on Aug. 03. Brief Summ... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749443) titled 'Construction and Empirical Study of Indirect Intervention Model for Protective Medical Lung ... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749326) titled 'Conventional Versus Stomach-Partitioning Gastrojejunostomy for Malignant Gastric Outlet Obst... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750080) titled 'The Effect of Multimodal Approach of Electrotherapy Versus Shock Wave Therapy in Menopausal ... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750522) titled 'Correlation Between MRI Findings and Clinical Improvement Following TMJ Injection With Hyalu... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748936) titled 'Chorioretinal Imaging, Vascular Biomarkers, and Ultra-Trail: A Pilot Study' on July 28. Bri... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749014) titled 'Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Place... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07751016) titled 'A Clinical Study of KH001 for Pulp Preservation and Safety in Deep Dentin Caries' on July 22... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749118) titled 'HB05P on Muscle Health' on Aug. 01. Brief Summary: The purpose of this pilot study is to ev... Read More
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749859) titled 'SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepa... Read More